Skip to main content Back to Top
Advertisement

7/7/2026

Calcitriol Injection

Products Affected - Description

    • Calcitriol injection, Fosun Pharma, 1 mcg/mL, 1 mL vial, 10 count, NDC 72266-0251-10

Reason for the Shortage

    • Fosun did not provide a reason for the shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Fosun has short-dated calcitriol 1 mcg/mL 1 mL vials available with an expiration date of August 2026.

Implications for Patient Care

    • Calcitriol is commonly used for the treatment of secondary hyperparathyroidism and metabolic bone disease in chronic kidney disease patients both on and off chronic hemodialysis, and hypocalcemia in patients with hypoparathyroidism and pseudohypoparathyroidism.[1]

Safety

    • Dosing is expressed in micrograms (mcg; not milligrams (mg))[1]
    • Unit conversion for Vitamin D: 1 international unit (IU) = 0.025 mcg[2]

Alternative Agents & Management

    • KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): https://kdigo.org/wp-content/uploads/2026/04/KDIGO-2017-CKD-MBD-Guideline.pdf
    Table -
    Drug NameVitamin D Form, Active/InactiveDosage Form and Strength
    Paricalcitol3 D2, ActiveIntravenous Solution
    · 2 mcg/mL
    · 5 mcg/mL
    · 10 mcg/mL
    Oral Capsule
    · 1 mcg
    · 2 mcg
    · 4 mcg
    Ergocalciferol4 D2, InactiveOral Capsule
    · 1250 mcg (50,000 units)
    Oral Solution
    · 200 mcg/mL
    Doxercalciferol5 D2, InactiveIntravenous Solution
    · 2 mcg/mL
    Oral Capsule
    · 0.5 mcg
    · 1 mcg
    · 2.5 mcg
    Calcitriol1 D3, ActiveIntravenous Solution
    · 1 mcg/mL
    · 2 mcg/mL
    Oral Solution
    · 1 mcg/mL
    Oral Capsule
    · 0.25 mcg
    · 0.5 mcg
    Cholecalciferol6 D3, InactiveOral Tablet
    Oral Capsule
    Oral Solution

    Various Strengths
    Calcifediol7 D3, InactiveOral Capsule
    · 30 mcg

References

    1. Calcitriol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.
    2. Unit Conversions. Dietary Supplement Ingredient Database. Updated January 1, 2026. Accessed July 1, 2026. https://dsid.od.nih.gov/unit-conversions.
    3. Paricalcitol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.
    4. Ergocalciferol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.
    5. Doxercalciferol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.
    6. Cholecalciferol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.
    7. Calcifediol. Lexicomp Online. Wolters Kluwer Clinical Drug Information. Hudson, Ohio, USA. Accessed July 1, 2026.

Updated

Updated July 7, 2026 by Rachael Freeman, PharmD, BCPS. Created July 2, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2026, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT